Trial
NCT02585388
Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
ARCAGY/ GINECO GROUP
Collaborators
Pierre Fabre Laboratories
Condition
Breast Cancer
Intervention
Vinorelbine
Why stopped
Treatment toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-06